CORTISPORIN® Ophthalmic Suspension Discontinued.

King Pharmaceuticals®, Inc. has decided to discontinue the manufacture of CORTISPORIN® Ophthalmic Suspension (neomycin and polymyxin B sulfates and hydrocortisone ophthalmic suspension).
CORTISPORIN® Ophthalmic Suspension will remain available through pharmacies and wholesalers until current supplies are depleted.
CORTISPORIN® Ophthalmic Suspension is distributed through King Pharmaceuticals®, Inc. No additional product will be available after King, pharmacy, and wholesaler supplies are exhausted.
If you have any questions or concerns, you may contact our Professional Information Services Department at 800-776-3637. CORTISPORIN® Ophthalmic Suspension (neomycin and polymyxin B sulfates and hydrocortisone ophthalmic suspension) is a sterile antimicrobial and anti-inflammatory suspension indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists.

Letter from King Pharmaceuticals

Tags: FDA Alert, Drug Discontinuation, CORTISPORIN® Ophthalmic Suspension